Evidence map›Paper›PMID 40598562›Full record

ArticleJournal of medical case reports2025

Acute interstitial nephritis and probable Vogt-Koyanagi-Harada disease following COVID-19 infection: a case report.

Nahid Aslani, Mohammad Malekahmadi, Alireza Merrikhi, Alaleh Gheisari, Aida Mardani, Kimia Afshar

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nahid AslaniDepartment of Pediatric Rheumatology, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad MalekahmadiIsfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
Alireza MerrikhiDepartment of Pediatric Nephrology, Isfahan University of Medical Sciences, Isfahan, Iran.
Alaleh GheisariDepartment of Pediatric Nephrology, Isfahan University of Medical Sciences, Isfahan, Iran.
Aida MardaniSchool of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Kimia AfsharStudent Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. kimia4433@gmail.com.ORCID http://orcid.org/0000-0002-9730-6801

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVogt-Koyanagi-Harada disease is an autoimmune inflammatory disease characterized by bilateral serous retinal detachment, which viral infections might induce. Coronavirus disease 2019 infection is thought to cause numerous autoimmune and inflammatory disorders. We report a case of Vogt-Koyanagi-Harada disease post-coronavirus disease 2019 infection in the pediatric population. CASE PRESENTATION: A 9-year-old Iranian girl with positive severe acute respiratory syndrome coronavirus 2 reverse transcription polymerase chain reaction presented with an elevated serum creatinine level due to acute interstitial nephritis that was treated with a high dose of corticosteroid. During corticosteroid tapering, she complained of reduced visual acuity in her right eye. After evaluation and imaging, diagnosis of unilateral Vogt-Koyanagi-Harada disease was made, and the patient was successfully treated with high-dose corticosteroid, methotrexate, and antitumor necrosis factor α.

conclusionCoronavirus disease 2019 infection could be a possible trigger factor for acute interstitial nephritis and Vogt-Koyanagi-Harada disease. Early diagnosis and treatment of these autoimmune features with corticosteroids and other antiinflammatory agents can help in faster improvement in these patients. In addition, it is crucial for physicians to consider Vogt-Koyanagi-Harada disease in pediatrics as one of the coronavirus disease 2019 complications for early diagnose and current treatment.

Indexed as

COVID-19Nephritis, InterstitialUveomeningoencephalitic SyndromeChildFemaleGlucocorticoidsHumansImmunosuppressive AgentsMethotrexateSARS-CoV-2Tumor Necrosis Factor-alphaGlucocorticoidsImmunosuppressive AgentsMethotrexateTumor Necrosis Factor-alphaAutoimmunityCOVID-19Nephritis-interstitialUveitisUveomeningoencephalitic syndrome

Identifiers

PMID40598562
PMCPMC12220733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.